Bank Of America Corp In Med Pharmaceuticals Inc. Transaction History
Bank Of America Corp
- $1.06 Trillion
- Q1 2024
A detailed history of Bank Of America Corp transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 100 shares of INM stock, worth $26. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$26
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$94,0494.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$69,4110.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.3KShares$7,3580.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.4KShares$4,0090.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,3080.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $236K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...